Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Creates New Sales Position; Ciphergen Names New CFO; Aebersold and Hood New EMBO Members; and Others

NEW YORK (GenomeWeb News) — Invitrogen has promoted Bernd Brust to senior vice president of sales for Europe and the Americas, a newly created position at the company. He had been general manager and vice president of European Operations.
Brust has been with Invitrogen since 2004 and worked as a sales and marketing manager at GE Medical Systems Information Technologies. The company said Brust’s direct marketing and web marketing work, along with persistent growth in his region, spurred them to create the new position. 
Invitrogen said Susan Lambert, vice president of European sales, will take over Brust’s previous role.

Ciphergen has appointed Debra Young as its vice president and CFO. Young most recently served as CFO of ViOptix, where she helped the company establish systems necessary for FDA clearance and worked on the company’s first product launch. Prior to that, Young was CFO of the nuclear medicine division at Philips Electronics.

The European Molecular Biology Organization has announced new members:
Ruedi Aebersold of the Institute of Molecular Systems Biology in Zurich, Switzerland; Jan Ellenberg of the European Microbiology Laboratory in Heidelberg, Germany; Lee Hood of the Institute for Systems Biology in Seattle; and Ulf Landegren of the Department of Genetics and Pathology at Uppsala University, Sweden.

DiaGenic has added four breast cancer experts to its scientific advisory board. The new additions include Martine Piccart, Anne-Lise Borrenson-Dale, Allan Hollingsworth and Christos Sotiriou.
Piccart is professor in oncology at the Université Libre of Brussels, head of medicine at the Jules Bordet Institute, president of the European Organization for Research and Treatment of Cancer, and is a recent member of the American Society of Clinical Oncology.
Borresen-Dale is head of the department of genetics at the Norwegian Radium Hospital, a board member of the Norwegian FUGE Functional Genomics Program, a committee member of the European Breast Cancer Linkage consortium and is a Member of The Board of Directors, American Association for Cancer Research.
Hollingsworth is medical director of Mercy Women’s Centre and Mercy Cancer Centre in Oklahoma City and a runs a genetic test-based breast cancer risk assessment practice.
Sotiriou is assistant professor at the Medical Oncology Unit and is head of the Functional Genomics & Translational Research Unit at the Jules Bordet Institute in the Université Libre of Brussels. His research focuses on genomics and molecular biology in breast cancer.

Metabolon has named Dan Stevens its new marketing director. He previously worked at SGI, where he served as director of life sciences and business development.

Cellumen has appointed Lee Hood to its scientific advisory board, the company said this week. Hood is president of the Institute for Systems Biology in Seattle

ExonHit Therapeutics has appointed Christophe Jean to its supervisory board.
Jean is currently executive vice president in charge of strategic planning at Ipsen. Jean has previously served in operations for nearly two decades at Ciba Geigy, and then at Novartis Pharma and as president at Pierre Fabre Medicament

Compugen has appointed Eli Zangvil to the position of vice president of business development, where he will focus on strategic alliances and other development activities.
Zangvil comes to Compugen from the Israeli company UltraShape, where he was COO, and before that from Israeli Defense Force, where he was head of medical services.
Compugen said Zangvil will help direct the company’s therapeutics, diagnostic biomarkers and research discovery segments, as well as working with the company’s corporate development strategies.

The World Health Organization has named Margaret Chan its next director-general.
Chan had been WHO’s assistant director-general for communicable diseases, a representative for the group’s director-general of pandemic influenza, and as director of health for Hong Kong.
While in Hong Kong, Chan led the response to outbreaks of SARS and the avian influenza.

Stephen Straus has stepped down from his post as director of the National Center for Complementary and Alternative Medicine for health reasons, the NCCAM said this week.
Straus has become senior advisor to NIH Director Elias Zerhouni.
Ruth Kischstein, former director of National Institute of General Medical Sciences and former acting director of the NIH, has taken over as acting director of the NCCAM.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.